Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Roblin

Showing results (41-50 of 252) with videos related to

Pageof 26
Sort By:
Inflammatory Bowel Diseases|March 16, 2016
Thiopurine Metabolism in the Era of CombotherapyXavier Roblin, Nicolas Williet, Laurent Peyrin-Biroulet
Gastroenterologie Clinique Et Biologique|May 8, 2007
[Steatosis, chronic hepatitis virus C infection and homocysteine]Xavier Roblin, Joanna Pofelski, Jean-Pierre Zarski
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 3, 2018
Should we set-up routine screening for primary sclerosing cholangitis in all IBD patients?Guillaume Bouguen, Miles Peter Sparrow, Xavier Roblin
Digestive Diseases and Sciences|July 26, 2006
Panic attack with suicide: an exceptional adverse effect of infliximabXavier Roblin, Paula Oltean, Frederic Heluwaert, et al.
Gastroenterology|October 6, 2009
Is ulcerative colitis proctitis associated with an increased risk of colorectal cancer?Laurent Peyrin-Biroulet, Jean-Marc Phelip, Xavier Roblin
Archives of Internal Medicine|January 24, 2007
Coffee and diabetes: is homocysteine the missing link?Laurent Peyrin-Biroulet, Jean-Louis Guéant, Xavier Roblin
Presse Medicale (Paris, France : 1983)|December 31, 2013
[Biomarkers in inflammatory bowel diseases]Xavier Roblin, Alaric Cavaille, Léa Clavel, et al.
European Journal of Gastroenterology & Hepatology|July 18, 2003
Unexplained hypertransaminasaemia: a clue to the diagnosis of Addison's diseaseXavier Roblin, J M Phelip, Haralampos J Milionis
Therapeutic Advances in Gastroenterology|May 19, 2018
Therapeutic drug monitoring of vedolizumab in inflammatory bowel disease: current data and future directionsMark G Ward, Miles P Sparrow, Xavier Roblin
Drugs|May 20, 2017
Advances in the Development of Janus Kinase Inhibitors in Inflammatory Bowel Disease: Future ProspectsMathurin Flamant, Josselin Rigaill, Stephane Paul, et al.
Pageof 26

Showing results (41-50 of 252) with videos related to

Sort By:
Pageof 26
Inflammatory Bowel Diseases|March 16, 2016
Thiopurine Metabolism in the Era of CombotherapyXavier Roblin, Nicolas Williet, Laurent Peyrin-Biroulet
Gastroenterologie Clinique Et Biologique|May 8, 2007
[Steatosis, chronic hepatitis virus C infection and homocysteine]Xavier Roblin, Joanna Pofelski, Jean-Pierre Zarski
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 3, 2018
Should we set-up routine screening for primary sclerosing cholangitis in all IBD patients?Guillaume Bouguen, Miles Peter Sparrow, Xavier Roblin
Digestive Diseases and Sciences|July 26, 2006
Panic attack with suicide: an exceptional adverse effect of infliximabXavier Roblin, Paula Oltean, Frederic Heluwaert, et al.
Gastroenterology|October 6, 2009
Is ulcerative colitis proctitis associated with an increased risk of colorectal cancer?Laurent Peyrin-Biroulet, Jean-Marc Phelip, Xavier Roblin
Archives of Internal Medicine|January 24, 2007
Coffee and diabetes: is homocysteine the missing link?Laurent Peyrin-Biroulet, Jean-Louis Guéant, Xavier Roblin
Presse Medicale (Paris, France : 1983)|December 31, 2013
[Biomarkers in inflammatory bowel diseases]Xavier Roblin, Alaric Cavaille, Léa Clavel, et al.
European Journal of Gastroenterology & Hepatology|July 18, 2003
Unexplained hypertransaminasaemia: a clue to the diagnosis of Addison's diseaseXavier Roblin, J M Phelip, Haralampos J Milionis
Therapeutic Advances in Gastroenterology|May 19, 2018
Therapeutic drug monitoring of vedolizumab in inflammatory bowel disease: current data and future directionsMark G Ward, Miles P Sparrow, Xavier Roblin
Drugs|May 20, 2017
Advances in the Development of Janus Kinase Inhibitors in Inflammatory Bowel Disease: Future ProspectsMathurin Flamant, Josselin Rigaill, Stephane Paul, et al.
Pageof 26